CSD PHARMA CONSULTING LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Summary
CSD PHARMA CONSULTING LTD is an active private limited company (company number 08725656) incorporated on 9 October 2013, registered in South Godstone. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest abridged accounts cover the period ending 31 October 2025, showing net assets of £128k and cash of £202k, with 1 employee on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 306% on the prior period (£31k). Across the last 3 periods on record the net-asset trend is rising.
By net assets it sits in the top quarter of 54 comparable companies in Surrey (median £1,000, upper quartile £121k).
Key dates
- Incorporated
- 9 October 201313 yrs ago
- Next accounts due
- 31 July 2027in 282 days
- Confirmation statement due
- 23 October 2027in 366 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £128k | £202k | £8,360 | — | — | — | 1 |
| 31 October 2024 | £31k | £74k | — | — | — | — | 1 |
| 31 October 2023 | £15k | £17k | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Positive net assetsNet assets £127,537 at 2025-10-31
- Net assets growing+306.2% vs prior period
- Cash at bank of £50,000 or moreCash £202,036
- Multi-year filing history3 periods on record
- Incorporated five or more years agoIncorporated 2013-10-09 (13 years)
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Ownership and control
- Mr Christopher Stuart Dott
- owns 50–75% of shares
- Mrs Jennifer Dott
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Confirmation statement duein 366 days
- Next accounts duein 282 days
- Accounts period endNet assets £128k · abridged accounts
- Accounts period endNet assets £31k · abridged accounts
- Accounts period endNet assets £15k · abridged accounts
- Incorporated
Similar companies in Surrey
- EPSILON BIOCONSULTING LIMITEDHaywards Heath · inc. Jun 2014
- HANSA BIOPHARMA LIMITEDGodalming · inc. Jan 2013
- CREST PHARMA LTDLightwater · inc. Jan 2013
- GLOBAL ALLIANCE FOR RESEARCH ON AVIAN DISEASES LIMITEDCamberley · inc. Aug 2014
- NATURE METRICS LTDGuildford · inc. Oct 2014
- SENTURION PHARMA LTDBurgess Hill · inc. Nov 2014
All companies incorporated on 9 October 2013 · in Oct 2013.
Reminders for CSD PHARMA CONSULTING LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.